Methylphenidate in Childhood Apraxia of Speech

Clinical trial NCT05185583 · COMPLETED

Trial details

NCT number: NCT05185583
Sponsor: Murdoch Childrens Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Childhood Apraxia of Speech

Start date: 2022-03-14
Primary completion: 2025-10-27
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.